Navigation Links
Omnicell to Release First Quarter 2013 Earnings Results on May 2
Date:4/25/2013

MOUNTAIN VIEW, Calif., April 25, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, May 2, to discuss the Company's First Quarter 2013 financial results.  What: 

Omnicell First Quarter 2013 earnings conference call and webcastWhen: 

May 2, 2013, 1:30 p.m. PTWho:Randall Lipps, chairman, president and chief executive officer

Rob Seim, chief financial officerWhere:

The conference call can be monitored by dialing 1-866-830-5685 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 45591563.

The webcast can be accessed at: http://ir.omnicell.com/events.cfm.How:  

Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.Replay:

Available starting at 3:30 p.m. PT on May 2, 2013 through 8:59 p.m. PT on June 2, 2013. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 45591563. (Logo:  http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

About Omnicell
For over 20 years the mission of Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
Since 1992, more than 2,600 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions that can reduce costly hospital readmissions and enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit www.omnicell.com

OMCL-E


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnicell Repeats Best in KLAS Award for OmniRx Automated Medication Dispensing System
2. Omnicell to Release Second Quarter 2012 Earnings Results on August 1
3. University of South Alabama Health System Selects Omnicell G4 Solutions
4. Omnicell Announces Second Quarter 2012 Results
5. Omnicell To Present At Think Equitys 9th Annual Growth Conference: G9
6. Omnicell Announces Record Revenue and Profit in Third Quarter 2012
7. Omnicell To Present At Lazard Capital Markets 9th Annual Healthcare Conference
8. Omnicell to Showcase Automation Solutions at Arab Health 2013
9. Omnicell to Present at the Cowen and Company 33rd Annual Health Care Conference
10. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
11. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2017)...   OrthoAtlanta has been named the official orthopedic ... (AFHC) for the 2018 College Football Playoff (CFP) National Championship ... Stadium in Atlanta, Georgia . OrthoAtlanta is ... campaign, participating in many activities leading up to, and including ... ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... 2017 , ... The Davidson Institute for Talent Development will ... 27 at a reception in Washington D.C. The recipients received $50,000, $25,000 and ... “I am honored to be a Davidson Fellow Laureate,” said Rishab Gargeya, a ...
(Date:9/19/2017)... Brook, IL (PRWEB) , ... September 19, 2017 ... ... are significantly and positively linked to the Certified Emergency Nurse (CEN®) certification ... for Emergency Nursing (BCEN). The value of certification study, conducted by the Human ...
(Date:9/18/2017)... (PRWEB) , ... September 19, 2017 , ... ... Asia Pacific’s protein ingredient market , expected to grow at the fastest CAGR ... Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in Asia’ – ...
(Date:9/18/2017)... ... September 18, 2017 , ... ... the finance role on the executive team adding a Chief Financial Officer following ... independent company. This expansion will support the strategic growth strategy Aegis has defined ...
(Date:9/18/2017)... Fort Lee, NJ (PRWEB) , ... September 18, 2017 , ... ... state’s history, CareOne, a New jersey based company, has launched an aid effort focused ... Irma as it battered the state over two days and left thousands homeless and ...
Breaking Medicine News(10 mins):